Published Social post

Wu Blockchain (@WuBlockchain): Coinbase Co-Founder Brian Armstrong;s Longevity Startup NewLimit Raises $435M Series C

Estimated coin impact

Scores are not price-change percentages. High impact means a score of +70 or more, or -70 or less.

Impact unavailable

Coinbase Co-Founder Brian Armstrong;s Longevity Startup NewLimit Raises $435M Series C NewLimit, a longevity biotech startup co-founded by Coinbase CEO Brian Armstrong, announced a $435 million Series C round led by Founders Fund. New investors including Thrive Capital, Greenoaks and Quiet Capital joined the round, with existing backers such as Kleiner Perkins and Eli Lilly Ventures also participating. NewLimit said it plans to advance its first age-reprogramming drug into human trials next year. Source: https://x.com/newlimit/status/2061849237156159511?s=20

Back to news archive